Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathwayKoji Ando, Ajit Bharti, Julian Taylor‐Parker et al.|Oncotarget|2017Cited by 27
Effect of DNA-PK dependent phosphorylation of topo-I-S10 on its rate of proteasomal degradation and CPT response.Ankur K. Shah, Ajit Bharti, Vibhu Sachdew et al.|Journal of Clinical Oncology|2015Cited by 1